Insulin Sensitizers like Metformin and GLP1 with Degludec as Anti-Aging

This commentary discusses the role of albumin, a crucial protein in human plasma, in the process of aging, and its connection to insulin signaling. The piece explores the potential of insulin sensitizers, specifically Metformin and GLP1 with Degludec, as innovative therapeutic strategies for promoting healthy aging. The work underlines the need for further research in understanding the multifunctional capabilities of albumin and its modulation by insulin sensitizers.